US Broker Ratings

Ligand Pharmaceuticals (LGND) Stock Analysis: Potential Upside and Strategic Growth in Biotechnology

Ligand Pharmaceuticals Inc. (NASDAQ: LGND), a prominent player in the biotechnology sector, has been capturing investor attention with its robust growth prospects and strategic initiatives. As a biopharmaceutical company, Ligand..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 50% Potential Upside in the Healthcare Sector

Vericel Corporation (NASDAQ: VCEL) has become an intriguing contender in the healthcare and biotechnology sectors, not just for its innovative cellular therapies but also for its compelling growth potential in..

Organon & Co. (OGN) Stock Analysis: A 44% Potential Upside in the Healthcare Sector

In a volatile market landscape, Organon & Co. (NYSE: OGN) presents an intriguing opportunity for investors with a potential upside of 44.03%, according to recent analyst ratings. With its robust..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 36.50% Upside Potential Amidst Healthcare Sector Volatility

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents a compelling investment opportunity with significant upside potential...

Viking Therapeutics, Inc. (VKTX) Stock Analysis: A 228% Potential Upside for This Biotech Play

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising portfolio of novel therapies targeting metabolic and endocrine disorders. With a..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth with a 3.62% Upside

Warby Parker Inc. (NYSE: WRBY) operates at the intersection of healthcare and fashion, carving out a niche in the medical instruments and supplies industry with its innovative approach to eyewear...

ImmunityBio, Inc. (IBRX) Stock Analysis: Uncovering a 319% Potential Upside in Biotech Innovation

ImmunityBio, Inc. (NASDAQ: IBRX), a pioneering force in the biotechnology sector, is attracting significant attention with its cutting-edge therapies aimed at enhancing the immune system’s ability to combat cancer and..

Mirum Pharmaceuticals (MIRM) Investor Outlook: Unpacking a 35.92% Potential Upside and Robust Revenue Growth

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the biotechnology sector, captivating investor interest with its promising potential upside and robust revenue growth. As a player in the healthcare..

SpringWorks Therapeutics, Inc. (SWTX): An Investor Outlook on the Biotech Innovator with a 133.70% Revenue Growth

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), a prominent player in the biotechnology sector, is making waves with its rapid revenue growth and innovative approach to treating rare diseases and cancer. With..

Crinetics Pharmaceuticals (CRNX): A Biotech Leader with 150% Upside Potential and Strong Buy Ratings

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands out in the biotechnology sector with its focus on discovering and developing novel therapeutics for rare endocrine diseases and endocrine-related tumors. As a clinical-stage..

Amedisys Inc (AMED) Investor Outlook: Strong Healthcare Growth with a Balanced Analyst Consensus

Amedisys Inc (AMED), a key player in the healthcare sector, is drawing investor attention with its strategic focus on home-based medical care services. Headquartered in Baton Rouge, Louisiana, Amedisys operates..

Merus N.V. (MRUS) Stock Analysis: A Strong Buy with a 71.55% Potential Upside

Merus N.V. (NASDAQ: MRUS), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to immuno-oncology. Based in the Netherlands, this clinical-stage company boasts a..

Haemonetics Corporation (HAE) Stock Analysis: Unveiling a 20.76% Potential Upside in Healthcare Innovation

Haemonetics Corporation (NYSE: HAE), a key player in the healthcare sector, is drawing attention from investors with a noteworthy potential upside of 20.76%. As a leading medical technology company, Haemonetics..

Concentra Group Holdings (CON) Stock Analysis: Healthcare Leader with a Promising 37% Upside

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a prominent player in the healthcare sector, specifically within the medical care facilities industry, offers a compelling investment opportunity. With a market cap..

ICU Medical, Inc. (ICUI) Stock Analysis: Navigating a 43.55% Potential Upside in the Healthcare Sector

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector specializing in medical instruments and supplies, is catching the eyes of investors with a compelling potential upside of..

CRISPR Therapeutics AG (CRSP) Stock Analysis: 59.71% Potential Upside Sparks Investor Interest

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering gene-editing company, continues to captivate investors with its cutting-edge CRISPR/Cas9 technology, which promises transformative advances in genetic medicine. Although the stock has recently..

Zai Lab Limited (ZLAB) Stock Analysis: A 53% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB) stands out in the biotechnology industry, not just for its innovative approach to addressing critical health conditions like oncology, immunology, neuroscience, and infectious diseases, but..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a 43% Upside Potential in Gene Therapy Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning leader in the biotechnology sector, has captured investor attention with its impressive market cap of $4.13 billion and a robust growth trajectory. As..

Integer Holdings Corporation (ITGR) Stock Analysis: Unlocking a 22.93% Potential Upside in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR), with its robust presence in the healthcare sector, stands out as a significant player in the medical device industry. Headquartered in Plano, Texas, and boasting..

Glaukos Corporation (GKOS) Stock Analysis: Strong Buy Ratings Signal Potential Upside for Investors

Glaukos Corporation (NYSE: GKOS), a key player in the healthcare sector’s medical devices industry, has been making waves with its innovative ophthalmic pharmaceutical and medical technology solutions. Headquartered in Aliso..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds